United States

Chiome Bioscience Inc (4583.T)

4583.T on Tokyo Stock Exchange

2:00am EDT
Change (% chg)

¥-2 (-0.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4583.T


Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in three business segments. The Drug Discovery Alliance segment is engaged in the research and development of antibodies which aims at the development of... (more)
No analyst recommendations are available for 4583.T.


Beta: 3.37
Market Cap(Mil.): ¥10,444.79
Shares Outstanding(Mil.): 26.78
Dividend: --
Yield (%): --


  4583.T Industry Sector
P/E (TTM): -- 79.56 32.84
EPS (TTM): -48.64 -- --
ROI: -26.35 2.86 14.86
ROE: -26.74 5.27 16.11

BRIEF-Chiome Bioscience receives patent in China regarding DLK-1 antibody

* Says it received a patent (No.201380051895.5) regarding DLK-1 antibody in China

Jul 21 2017

BRIEF- Chiome Bioscience announces exercise of options

* Says 820 units of its 13th series options were exercised to 820,000 shares of its common stock from June 1 to June 27

Jun 27 2017

BRIEF-Chiome Bioscience receives TROP-2 antibody related patent in China

* Says it received a TROP-2 antibody related patent, Anti-Human Trop-2 Antibody Having Antitumor Activity In Vivo, (application No.201280057258.4) in China on June 5

Jun 05 2017

BRIEF-Chiome Bioscience receives patent in US

* Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

Mar 14 2017

Earnings vs. Estimates